Clinical Trials Browser

Sarcoma × Doxorubicin × Breast × Clear all

NCT03678883 2024-11-07

9-ING-41 in Patients with Advanced Cancers

Phase 2 Active not recruiting

BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

NCT02076620 2022-04-04

L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours

Phase 1 Completed

Breast Neoplasms, Sarcoma

NCT01375699 2019-08-26

Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Phase 1 Completed

BreastGastrointestinalSarcoma

Breast Neoplasms, Gastrointestinal Neoplasms, Sarcoma, Urogenital Neoplasms

NCT00722293 2017-11-13

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Phase 1 Completed

BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma